BioSpace News Archive

BioFluidica, a privately held biotechnology company, announced they have been awarded a continuation grant from the Midwest Biomedical Accelerator Research Consortium on behalf of the National Institutes of Health Rapid Acceleration of Diagnostics program.

Biosimilar Solutions, Inc. announces it has started its registrational clinical trials for BSC1020®, a recombinant filgrastim product tested for biosimilarity with its reference product, Neupogen®.

During the virtual conference, investors will hear from executives from a wide range of sectors, including Biotech, Clean Energy, Electric Vehicles, Financial Services, Fintech & REITs, Gaming & Entertainment, Healthcare, Healthcare IT, Infrastructure, Shipping and Technology/Media/Telecom.

i2i Population Health is excited to announce the company has been selected as a Pipeline Partner of the National Rural Health Association.

SpineX, Inc., an early stage medtech company today announced the publication of new data in the esteemed journal, BioElectric Medicine demonstrating the positive effects of SCONE™ therapy to treat Urge Urinary Incontinence. SCONE™, a non-invasive transcutaneous spinal cord neuromodulator is the first of its kind device that is being developed to treat bladder dysfunction.

The report offers detailed overview of the market with recent market dynamics and industrial status.

The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times.

Increase in incidences of diabetics coupled with technological advancements globally are the major factors influencing market growth.

Rising incidence of osteoarthritis and arthritis globally is a major factor influencing market growth.

The growing health concern, vitamin deficiency, and changing lifestyle and dietary habits are driving the demand for the calcium pantothenate market.